Endometrial
RAINFOL-03 (GCT1184-03)
Phase III Study to assess the efficacy and safety of ADC compared to treatment of investigator’s choice in participants with endometrial cancer
Trial overview
Clinical Area
Medical Oncology
Disease
Endometrial
Disease site
Gynaecology
Study Phase
III
Trial Identifiers
Registration number: NCT07166094
Principal Investigator(s)
··
··